ARCHIVES

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

Advisors suggest NCI establish sarcoma research consortium.

January 30, 2004

NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements

December 5, 2014

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Commemoration Planned For Heidelberger

February 11, 1983

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984